Neovasc (NVCN) Stock Price, News & Analysis

Neovasc Inc. (NASDAQ:NVCN) released its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) earnings per share for the quarter, missing analysts' consensus estimates of ($2.25) by $0.50. The medical equipment provider had revenue of $0.70 million for the quarter, compared to analysts' expectations of $1.20 million. Neovasc had a negative net margin of 1,082.92% and a negative trailing twelve-month return on equity of 127.25%. During the same quarter in the previous year, the business earned ($12.75) EPS.

Shares of Neovasc reverse split on Friday, April 29th 2022. The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), Amicus Therapeutics (FOLD), Synergy Pharmaceuticals (SGYP), Rexahn Pharmaceuticals (REXN), Heat Biologics (HTBX), Palatin Technologies (PTN), Amarin (AMRN).